These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 1832771

  • 1. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice.
    Kohler SW, Provost GS, Fieck A, Kretz PL, Bullock WO, Sorge JA, Putman DL, Short JM.
    Proc Natl Acad Sci U S A; 1991 Sep 15; 88(18):7958-62. PubMed ID: 1832771
    [Abstract] [Full Text] [Related]

  • 2. Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector.
    Kohler SW, Provost GS, Fieck A, Kretz PL, Bullock WO, Putman DL, Sorge JA, Short JM.
    Environ Mol Mutagen; 1991 Sep 15; 18(4):316-21. PubMed ID: 1836179
    [Abstract] [Full Text] [Related]

  • 3. The use of transgenic mice for short-term, in vivo mutagenicity testing.
    Kohler SW, Provost GS, Kretz PL, Fieck A, Sorge JA, Short JM.
    Genet Anal Tech Appl; 1990 Dec 15; 7(8):212-8. PubMed ID: 2151115
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
    Monroe JJ, Kort KL, Miller JE, Marino DR, Skopek TR.
    Mutat Res; 1998 Oct 12; 421(1):121-36. PubMed ID: 9748534
    [Abstract] [Full Text] [Related]

  • 5. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
    Stuart GR, Gorelick NJ, Andrews JL, de Boer JG, Glickman BW.
    Environ Mol Mutagen; 1996 Oct 12; 28(4):385-92. PubMed ID: 8991067
    [Abstract] [Full Text] [Related]

  • 6. Development of a short-term, in vivo mutagenesis assay: the effects of methylation on the recovery of a lambda phage shuttle vector from transgenic mice.
    Kohler SW, Provost GS, Kretz PL, Dycaico MJ, Sorge JA, Short JM.
    Nucleic Acids Res; 1990 May 25; 18(10):3007-13. PubMed ID: 1693420
    [Abstract] [Full Text] [Related]

  • 7. Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacI transgenic mouse mutagenesis assay (I).
    Rogers BJ, Provost GS, Young RR, Putman DL, Short JM.
    Mutat Res; 1995 Mar 25; 327(1-2):57-66. PubMed ID: 7870099
    [Abstract] [Full Text] [Related]

  • 8. Development of a rat cell line containing stably integrated copies of a lambda/lacI shuttle vector.
    Wyborski DL, Malkhosyan S, Moores J, Perucho M, Short JM.
    Mutat Res; 1995 Apr 25; 334(2):161-5. PubMed ID: 7885368
    [Abstract] [Full Text] [Related]

  • 9. Spontaneous mutations in lacI-containing lambda lysogens derived from transgenic mice: the observed patterns differ in liver and spleen.
    Knöll A, Jacobson DP, Kretz PL, Lundberg KS, Short JM, Sommer SS.
    Mutat Res; 1994 Nov 01; 311(1):57-67. PubMed ID: 7526175
    [Abstract] [Full Text] [Related]

  • 10. Ethylnitrosourea-induced mutation and molecular analysis of transgenic mice containing the gpt shuttle vector.
    Yamada T, Yamamoto R, Kaneko H, Yoshitake A.
    Mutat Res; 1999 Apr 26; 441(1):59-72. PubMed ID: 10224323
    [Abstract] [Full Text] [Related]

  • 11. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L, Saranko CJ, Steen AM.
    Res Rep Health Eff Inst; 2000 Mar 26; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [Abstract] [Full Text] [Related]

  • 12. Methylation of CpG dinucleotides in the lacI gene of the Big Blue transgenic mouse.
    You YH, Halangoda A, Buettner V, Hill K, Sommer S, Pfeifer G.
    Mutat Res; 1998 Dec 03; 420(1-3):55-65. PubMed ID: 9838042
    [Abstract] [Full Text] [Related]

  • 13. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice.
    Barnett LB, Tyl RW, Shane BS, Shelby MD, Lewis SE.
    Environ Mol Mutagen; 2002 Dec 03; 40(4):251-7. PubMed ID: 12489115
    [Abstract] [Full Text] [Related]

  • 14. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
    Zimmer DM, Harbach PR, Mattes WB, Aaron CS.
    Environ Mol Mutagen; 1999 Dec 03; 33(3):249-56. PubMed ID: 10334627
    [Abstract] [Full Text] [Related]

  • 15. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
    Skopek TR, Kort KL, Marino DR, Mittal LV, Umbenhauer DR, Laws GM, Adams SP.
    Environ Mol Mutagen; 1996 Dec 03; 28(4):376-84. PubMed ID: 8991066
    [Abstract] [Full Text] [Related]

  • 16. Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy.
    Shane BS, Lockhart AM, Winston GW, Tindall KR.
    Mutat Res; 1997 Jun 09; 377(1):1-11. PubMed ID: 9219573
    [Abstract] [Full Text] [Related]

  • 17. Development of a lambda-based complementation assay for the preliminary localization of lacI mutants from the Big Blue mouse: implications for a DNA-sequencing strategy.
    Gu M, Ahmed A, Wei C, Gorelick N, Glickman BW.
    Mutat Res; 1994 Jun 01; 307(2):533-40. PubMed ID: 7514727
    [Abstract] [Full Text] [Related]

  • 18. Effect of target gene CpG content on spontaneous mutation in299 transgenic mice.
    Skopek T, Marino D, Kort K, Miller J, Trumbauer M, Gopal S, Chen H.
    Mutat Res; 1998 May 25; 400(1-2):77-88. PubMed ID: 9685590
    [Abstract] [Full Text] [Related]

  • 19. Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived.
    Hill KA, Buettner VL, Glickman BW, Sommer SS.
    Mutat Res; 1999 Jan 25; 436(1):11-9. PubMed ID: 9878678
    [Abstract] [Full Text] [Related]

  • 20. LacI mutation spectra following benzo[a]pyrene treatment of Big Blue mice.
    Shane BS, de Boer J, Watson DE, Haseman JK, Glickman BW, Tindall KR.
    Carcinogenesis; 2000 Apr 25; 21(4):715-25. PubMed ID: 10753208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.